Protocol for a national blood transfusion data warehouse from donor to recipient

Introduction Blood transfusion has health-related, economical and safety implications. In order to optimise the transfusion chain, comprehensive research data are needed. The Dutch Transfusion Data warehouse (DTD) project aims to establish a data warehouse where data from donors and transfusion recipients are linked. This paper describes the design of the data warehouse, challenges and illustrative applications. Study design and methods Quantitative data on blood donors (eg, age, blood group, antibodies) and products (type of product, processing, storage time) are obtained from the national blood bank. These are linked to data on the transfusion recipients (eg, transfusions administered, patient diagnosis, surgical procedures, laboratory parameters), which are extracted from hospital electronic health records. Applications Expected scientific contributions are illustrated for 4 applications: determine risk factors, predict blood use, benchmark blood use and optimise process efficiency. For each application, examples of research questions are given and analyses planned. Conclusions The DTD project aims to build a national, continuously updated transfusion data warehouse. These data have a wide range of applications, on the donor/production side, recipient studies on blood usage and benchmarking and donor–recipient studies, which ultimately can contribute to the efficiency and safety of blood transfusion.

[1]  H. Hjalgrim,et al.  Epidemiological considerations for the use of databases in transfusion research: a Scandinavian perspective , 2010, Current opinion in hematology.

[2]  G. Bonsel,et al.  The PROTON study: profiles of blood product transfusion recipients in the Netherlands , 2010, Vox sanguinis.

[3]  Jeannie Callum,et al.  Age of transfused blood in critically ill adults. , 2015, The New England journal of medicine.

[4]  Mart P Janssen,et al.  Demographic changes and predicting blood supply and demand in the Netherlands , 2010, Transfusion.

[5]  G. Grunkemeier,et al.  Effect of hospital culture on blood transfusion in cardiac procedures. , 2013, The Annals of thoracic surgery.

[6]  G. Burch.  Of clinical data. , 1977, American heart journal.

[7]  M. Melbye,et al.  Post‐transfusion mortality among recipients of ABO‐compatible but non‐identical plasma , 2009, Vox sanguinis.

[8]  M. Germain,et al.  The impact of increasing the upper age limit of donation on the eligible blood donor population in Canada , 2012, Transfusion medicine.

[9]  M. Murphy,et al.  Concepts of blood transfusion in adults , 2013, The Lancet.

[10]  A. Forster,et al.  Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor–recipient continuum , 2015, BMJ Open.

[11]  C. Hillyer,et al.  The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006 , 2008, Transfusion.

[12]  A. Eder,et al.  Evidence‐based selection criteria to protect blood donors , 2010, Journal of clinical apheresis.

[13]  N. Heddle,et al.  Benchmarking: applications to transfusion medicine. , 2012, Transfusion medicine reviews.

[14]  L. Wideroff,et al.  Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study , 2007, The Lancet.

[15]  T. Maki.  Optimizing blood usage through benchmarking , 2007, Transfusion.

[16]  J. Ahonen,et al.  Transfusion of red blood cells: no impact on length of hospital stay in moderately anaemic parturients , 2007, Acta anaesthesiologica Scandinavica.

[17]  Gabriel J Escobar,et al.  Predicting red blood cell transfusion in hospitalized patients: role of hemoglobin level, comorbidities, and illness severity , 2014, BMC Health Services Research.

[18]  M. Suistomaa,et al.  Development of permanent national register of blood component use utilizing electronic hospital information systems , 2006, Vox sanguinis.

[19]  L. Wideroff,et al.  Cancer incidence in blood transfusion recipients. , 2007, Journal of the National Cancer Institute.

[20]  E. Briët,et al.  Mortality after transfusions, relation to donor sex , 2011, Vox sanguinis.

[21]  J. Carson,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.

[22]  By Alexander Goodall.  Transfusion of Blood , 1919, Edinburgh Medical Journal.

[23]  M Reilly,et al.  A population‐based binational register for monitoring long‐term outcome and possible disease concordance among blood donors and recipients , 2006, Vox sanguinis.

[24]  J. Vincent,et al.  Transfusion Requirements in Surgical Oncology Patients: A Prospective, Randomized Controlled Trial , 2015, Anesthesiology.

[25]  Kjell Titlestad,et al.  The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility , 2015, Transfusion.

[26]  S. Howard,et al.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? , 2007, Transfusion medicine reviews.

[27]  D. Devine,et al.  Challenges in the management of the blood supply , 2013, The Lancet.

[28]  L. Goodnough.  Blood management: transfusion medicine comes of age , 2013, The Lancet.

[29]  I. Tomasini,et al.  Red cell transfusion in orthopaedic surgery: a benchmark study performed combining data from different data sources. , 2011, Blood transfusion = Trasfusione del sangue.

[30]  H. Ullum,et al.  Duration of red blood cell storage and survival of transfused patients (CME) , 2010, Transfusion.

[31]  O. Nyrén,et al.  The impact of plasma preparations and their storage time on short-term posttransfusion mortality: A population-based study using the Scandinavian Donation and Transfusion database , 2012, The journal of trauma and acute care surgery.

[32]  J. Carson,et al.  Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. , 2013, JAMA.

[33]  Yang Liu,et al.  Factors affecting the frequency of red blood cell outdates: an approach to establish benchmarking targets , 2009, Transfusion.

[34]  P. Rehak,et al.  The second Austrian benchmark study for blood use in elective surgery: results and practice change , 2014, Transfusion.

[35]  G. Bonsel,et al.  Survival after transfusion in the Netherlands , 2011, Vox sanguinis.

[36]  S. Glynn,et al.  The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS‐III): a research program striving to improve blood donor and transfusion recipient outcomes , 2014, Transfusion.

[37]  P. Warner,et al.  REVIEWS: A review of methods used in comprehensive, descriptive studies that relate red blood cell transfusion to clinical data , 2009, Transfusion.

[38]  A. Ejaz,et al.  Variation in triggers and use of perioperative blood transfusion in major gastrointestinal surgery , 2014, The British journal of surgery.

[39]  O. Nyrén,et al.  Should plasma from female donors be avoided? A population‐based cohort study of plasma recipients in Sweden from 1990 through 2002 , 2010, Transfusion.

[40]  M. Mathru.  A solution to the problem of studying blood donor–related risk factors when patients have received multiple transfusions , 2011 .